Structure

Physi-Chem Properties

Molecular Weight:  430.24
Volume:  446.289
LogP:  3.061
LogD:  2.287
LogS:  -3.935
# Rotatable Bonds:  4
TPSA:  104.06
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.361
Synthetic Accessibility Score:  5.151
Fsp3:  0.68
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.642
MDCK Permeability:  1.6109437638078816e-05
Pgp-inhibitor:  0.969
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.056
20% Bioavailability (F20%):  0.013
30% Bioavailability (F30%):  0.07

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.887
Plasma Protein Binding (PPB):  61.06938171386719%
Volume Distribution (VD):  1.268
Pgp-substrate:  26.797887802124023%

ADMET: Metabolism

CYP1A2-inhibitor:  0.054
CYP1A2-substrate:  0.254
CYP2C19-inhibitor:  0.45
CYP2C19-substrate:  0.752
CYP2C9-inhibitor:  0.554
CYP2C9-substrate:  0.075
CYP2D6-inhibitor:  0.077
CYP2D6-substrate:  0.102
CYP3A4-inhibitor:  0.653
CYP3A4-substrate:  0.232

ADMET: Excretion

Clearance (CL):  2.949
Half-life (T1/2):  0.508

ADMET: Toxicity

hERG Blockers:  0.247
Human Hepatotoxicity (H-HT):  0.813
Drug-inuced Liver Injury (DILI):  0.29
AMES Toxicity:  0.019
Rat Oral Acute Toxicity:  0.971
Maximum Recommended Daily Dose:  0.99
Skin Sensitization:  0.918
Carcinogencity:  0.173
Eye Corrosion:  0.003
Eye Irritation:  0.024
Respiratory Toxicity:  0.973

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC71889

Natural Product ID:  NPC71889
Common Name*:   GFAGCYRBGVCTPP-MDYQULRUSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  GFAGCYRBGVCTPP-MDYQULRUSA-N
Standard InCHI:  InChI=1S/C25H34O6/c1-7-13(2)21(28)31-24-10-15(4)25(30)17(19(24)22(24,5)6)9-16(12-26)11-23(29)18(25)8-14(3)20(23)27/h7-9,15,17-19,26,29-30H,10-12H2,1-6H3/b13-7+/t15-,17+,18-,19-,23-,24+,25-/m1/s1
SMILES:  C/C=C(/C(=O)O[C@@]12C[C@@H](C)[C@]3([C@H]([C@@H]1C2(C)C)C=C(CO)C[C@]1([C@H]3C=C(C1=O)C)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL486021
PubChem CID:   6506231
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0002875] Tigliane and ingenane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19062 Euphorbia coerulescens Species Euphorbiaceae Eukaryota latices South African n.a. PMID[3236005]
NPO25960 Euphorbia triangularis Species Euphorbiaceae Eukaryota latices South African n.a. PMID[3236005]
NPO32447 euphorbia ledienii Species Euphorbiaceae Eukaryota latices South African n.a. PMID[3236005]
NPO19062 Euphorbia coerulescens Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25960 Euphorbia triangularis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus Activity = 0.28 nmol PMID[531562]
NPT32 Organism Mus musculus Mus musculus Activity = 3.6 /nmol PMID[531562]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC71889 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9905 High Similarity NPC474872
0.9808 High Similarity NPC260786
0.9808 High Similarity NPC474871
0.9808 High Similarity NPC475937
0.9808 High Similarity NPC174471
0.9808 High Similarity NPC158523
0.9808 High Similarity NPC96739
0.9714 High Similarity NPC221511
0.9714 High Similarity NPC265499
0.9714 High Similarity NPC17138
0.9714 High Similarity NPC170212
0.9714 High Similarity NPC475391
0.9714 High Similarity NPC101825
0.9714 High Similarity NPC89227
0.9714 High Similarity NPC151216
0.9714 High Similarity NPC215643
0.9712 High Similarity NPC153036
0.963 High Similarity NPC472760
0.9623 High Similarity NPC474937
0.9541 High Similarity NPC180640
0.9455 High Similarity NPC471128
0.9455 High Similarity NPC185876
0.9455 High Similarity NPC157252
0.9455 High Similarity NPC145182
0.9455 High Similarity NPC471126
0.9455 High Similarity NPC19336
0.9369 High Similarity NPC52839
0.9358 High Similarity NPC153651
0.9273 High Similarity NPC472397
0.9273 High Similarity NPC471125
0.9273 High Similarity NPC171905
0.9273 High Similarity NPC472758
0.9266 High Similarity NPC154363
0.9266 High Similarity NPC234858
0.9266 High Similarity NPC471127
0.9259 High Similarity NPC477091
0.9204 High Similarity NPC472399
0.9189 High Similarity NPC22628
0.9189 High Similarity NPC471108
0.9189 High Similarity NPC275696
0.9189 High Similarity NPC5991
0.9189 High Similarity NPC255081
0.9189 High Similarity NPC5989
0.9182 High Similarity NPC10721
0.9182 High Similarity NPC156252
0.9123 High Similarity NPC145238
0.9115 High Similarity NPC257017
0.9115 High Similarity NPC162009
0.9083 High Similarity NPC472757
0.9027 High Similarity NPC472401
0.9018 High Similarity NPC236918
0.9018 High Similarity NPC156745
0.9 High Similarity NPC472400
0.8947 High Similarity NPC19464
0.8938 High Similarity NPC475885
0.8938 High Similarity NPC472759
0.8938 High Similarity NPC329080
0.8929 High Similarity NPC124676
0.8929 High Similarity NPC146280
0.8879 High Similarity NPC222307
0.8729 High Similarity NPC270109
0.8716 High Similarity NPC163004
0.8571 High Similarity NPC236999
0.8475 Intermediate Similarity NPC473919
0.8475 Intermediate Similarity NPC473709
0.839 Intermediate Similarity NPC473802
0.8333 Intermediate Similarity NPC471940
0.8288 Intermediate Similarity NPC322903
0.825 Intermediate Similarity NPC471939
0.8214 Intermediate Similarity NPC273433
0.8205 Intermediate Similarity NPC472667
0.8165 Intermediate Similarity NPC476081
0.8165 Intermediate Similarity NPC162973
0.8148 Intermediate Similarity NPC470074
0.8148 Intermediate Similarity NPC474718
0.8145 Intermediate Similarity NPC476111
0.8142 Intermediate Similarity NPC257240
0.8142 Intermediate Similarity NPC5103
0.8125 Intermediate Similarity NPC476479
0.8103 Intermediate Similarity NPC148458
0.8095 Intermediate Similarity NPC243902
0.8087 Intermediate Similarity NPC469454
0.8087 Intermediate Similarity NPC469463
0.8087 Intermediate Similarity NPC25909
0.8087 Intermediate Similarity NPC469496
0.8073 Intermediate Similarity NPC471412
0.807 Intermediate Similarity NPC317107
0.8036 Intermediate Similarity NPC187435
0.8036 Intermediate Similarity NPC67321
0.8018 Intermediate Similarity NPC118911
0.8 Intermediate Similarity NPC123855
0.8 Intermediate Similarity NPC71348
0.8 Intermediate Similarity NPC475038
0.8 Intermediate Similarity NPC109195
0.8 Intermediate Similarity NPC317687
0.8 Intermediate Similarity NPC469674
0.8 Intermediate Similarity NPC469673
0.8 Intermediate Similarity NPC76550
0.8 Intermediate Similarity NPC222688
0.7984 Intermediate Similarity NPC220757
0.7984 Intermediate Similarity NPC196921
0.7983 Intermediate Similarity NPC143755
0.7982 Intermediate Similarity NPC477103
0.7982 Intermediate Similarity NPC471413
0.7982 Intermediate Similarity NPC47024
0.7965 Intermediate Similarity NPC275539
0.7965 Intermediate Similarity NPC189075
0.7951 Intermediate Similarity NPC15095
0.7949 Intermediate Similarity NPC176840
0.7949 Intermediate Similarity NPC270958
0.7949 Intermediate Similarity NPC179626
0.7946 Intermediate Similarity NPC472645
0.7946 Intermediate Similarity NPC179891
0.7937 Intermediate Similarity NPC476823
0.7934 Intermediate Similarity NPC469789
0.7931 Intermediate Similarity NPC474271
0.7931 Intermediate Similarity NPC46269
0.7931 Intermediate Similarity NPC106395
0.7931 Intermediate Similarity NPC159333
0.7931 Intermediate Similarity NPC202889
0.7928 Intermediate Similarity NPC478057
0.7928 Intermediate Similarity NPC476237
0.7928 Intermediate Similarity NPC120321
0.792 Intermediate Similarity NPC34963
0.792 Intermediate Similarity NPC90814
0.792 Intermediate Similarity NPC475139
0.792 Intermediate Similarity NPC180902
0.792 Intermediate Similarity NPC189393
0.7917 Intermediate Similarity NPC310511
0.7917 Intermediate Similarity NPC67569
0.7913 Intermediate Similarity NPC475480
0.7913 Intermediate Similarity NPC179798
0.7913 Intermediate Similarity NPC473921
0.7913 Intermediate Similarity NPC475668
0.7913 Intermediate Similarity NPC304180
0.7903 Intermediate Similarity NPC221414
0.7903 Intermediate Similarity NPC35109
0.7899 Intermediate Similarity NPC472933
0.7899 Intermediate Similarity NPC475041
0.7895 Intermediate Similarity NPC477102
0.789 Intermediate Similarity NPC222011
0.789 Intermediate Similarity NPC216478
0.7881 Intermediate Similarity NPC239273
0.7881 Intermediate Similarity NPC473656
0.7881 Intermediate Similarity NPC475323
0.7876 Intermediate Similarity NPC143609
0.7876 Intermediate Similarity NPC110496
0.787 Intermediate Similarity NPC29952
0.787 Intermediate Similarity NPC234993
0.787 Intermediate Similarity NPC134072
0.787 Intermediate Similarity NPC284518
0.787 Intermediate Similarity NPC202833
0.7863 Intermediate Similarity NPC133677
0.7863 Intermediate Similarity NPC138303
0.7863 Intermediate Similarity NPC67290
0.7863 Intermediate Similarity NPC238667
0.7857 Intermediate Similarity NPC58029
0.7857 Intermediate Similarity NPC258532
0.7857 Intermediate Similarity NPC72255
0.7851 Intermediate Similarity NPC470265
0.7851 Intermediate Similarity NPC23786
0.7845 Intermediate Similarity NPC475524
0.7845 Intermediate Similarity NPC4573
0.7845 Intermediate Similarity NPC277769
0.7845 Intermediate Similarity NPC269530
0.7845 Intermediate Similarity NPC138757
0.7845 Intermediate Similarity NPC470063
0.7845 Intermediate Similarity NPC90952
0.7845 Intermediate Similarity NPC100267
0.784 Intermediate Similarity NPC241935
0.784 Intermediate Similarity NPC279478
0.784 Intermediate Similarity NPC476855
0.7838 Intermediate Similarity NPC118405
0.7838 Intermediate Similarity NPC136289
0.7838 Intermediate Similarity NPC478156
0.7838 Intermediate Similarity NPC137430
0.7838 Intermediate Similarity NPC474709
0.7833 Intermediate Similarity NPC17938
0.7826 Intermediate Similarity NPC475563
0.7826 Intermediate Similarity NPC475134
0.7823 Intermediate Similarity NPC476859
0.7823 Intermediate Similarity NPC470850
0.7818 Intermediate Similarity NPC306856
0.7818 Intermediate Similarity NPC476274
0.7815 Intermediate Similarity NPC186525
0.7815 Intermediate Similarity NPC475372
0.7815 Intermediate Similarity NPC118638
0.7815 Intermediate Similarity NPC257457
0.7815 Intermediate Similarity NPC311554
0.7807 Intermediate Similarity NPC308191
0.7807 Intermediate Similarity NPC306265
0.7805 Intermediate Similarity NPC63186
0.7805 Intermediate Similarity NPC217901
0.7805 Intermediate Similarity NPC293112
0.7798 Intermediate Similarity NPC474343
0.7798 Intermediate Similarity NPC254496
0.7798 Intermediate Similarity NPC69385
0.7798 Intermediate Similarity NPC473963
0.7797 Intermediate Similarity NPC470793
0.7797 Intermediate Similarity NPC64318

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC71889 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8142 Intermediate Similarity NPD6371 Approved
0.7658 Intermediate Similarity NPD7640 Approved
0.7658 Intermediate Similarity NPD7639 Approved
0.7652 Intermediate Similarity NPD6899 Approved
0.7652 Intermediate Similarity NPD6881 Approved
0.7632 Intermediate Similarity NPD6402 Approved
0.7632 Intermediate Similarity NPD5739 Approved
0.7632 Intermediate Similarity NPD6675 Approved
0.7632 Intermediate Similarity NPD7128 Approved
0.7607 Intermediate Similarity NPD6650 Approved
0.7607 Intermediate Similarity NPD6649 Approved
0.7586 Intermediate Similarity NPD6372 Approved
0.7586 Intermediate Similarity NPD6373 Approved
0.7583 Intermediate Similarity NPD7115 Discovery
0.7568 Intermediate Similarity NPD7638 Approved
0.7565 Intermediate Similarity NPD5697 Approved
0.7521 Intermediate Similarity NPD7290 Approved
0.7521 Intermediate Similarity NPD6883 Approved
0.7521 Intermediate Similarity NPD7102 Approved
0.75 Intermediate Similarity NPD7320 Approved
0.7458 Intermediate Similarity NPD6847 Approved
0.7458 Intermediate Similarity NPD6617 Approved
0.7458 Intermediate Similarity NPD8130 Phase 1
0.7458 Intermediate Similarity NPD6869 Approved
0.7436 Intermediate Similarity NPD6014 Approved
0.7436 Intermediate Similarity NPD6013 Approved
0.7436 Intermediate Similarity NPD6012 Approved
0.7414 Intermediate Similarity NPD5701 Approved
0.7395 Intermediate Similarity NPD6882 Approved
0.7395 Intermediate Similarity NPD8297 Approved
0.7368 Intermediate Similarity NPD5211 Phase 2
0.736 Intermediate Similarity NPD7604 Phase 2
0.735 Intermediate Similarity NPD6011 Approved
0.7333 Intermediate Similarity NPD4632 Approved
0.7328 Intermediate Similarity NPD6008 Approved
0.7321 Intermediate Similarity NPD6083 Phase 2
0.7321 Intermediate Similarity NPD6084 Phase 2
0.7288 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7281 Intermediate Similarity NPD5344 Discontinued
0.7265 Intermediate Similarity NPD7899 Clinical (unspecified phase)
0.7258 Intermediate Similarity NPD6319 Approved
0.7257 Intermediate Similarity NPD4225 Approved
0.725 Intermediate Similarity NPD6053 Discontinued
0.7241 Intermediate Similarity NPD5141 Approved
0.7227 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD5286 Approved
0.7193 Intermediate Similarity NPD5285 Approved
0.7193 Intermediate Similarity NPD4696 Approved
0.7168 Intermediate Similarity NPD4755 Approved
0.7167 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD7492 Approved
0.7154 Intermediate Similarity NPD6009 Approved
0.7143 Intermediate Similarity NPD1698 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5695 Phase 3
0.712 Intermediate Similarity NPD6054 Approved
0.7109 Intermediate Similarity NPD7507 Approved
0.7109 Intermediate Similarity NPD6616 Approved
0.7105 Intermediate Similarity NPD5696 Approved
0.7103 Intermediate Similarity NPD1696 Phase 3
0.7073 Intermediate Similarity NPD6274 Approved
0.7069 Intermediate Similarity NPD5226 Approved
0.7069 Intermediate Similarity NPD5224 Approved
0.7069 Intermediate Similarity NPD5225 Approved
0.7069 Intermediate Similarity NPD7632 Discontinued
0.7069 Intermediate Similarity NPD4633 Approved
0.7063 Intermediate Similarity NPD5983 Phase 2
0.7059 Intermediate Similarity NPD6686 Approved
0.7054 Intermediate Similarity NPD7078 Approved
0.7043 Intermediate Similarity NPD6648 Approved
0.7043 Intermediate Similarity NPD4700 Approved
0.704 Intermediate Similarity NPD7100 Approved
0.704 Intermediate Similarity NPD7101 Approved
0.7009 Intermediate Similarity NPD5174 Approved
0.7009 Intermediate Similarity NPD5175 Approved
0.7008 Intermediate Similarity NPD6370 Approved
0.7 Intermediate Similarity NPD7736 Approved
0.7 Intermediate Similarity NPD1695 Approved
0.6991 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6984 Remote Similarity NPD6059 Approved
0.6983 Remote Similarity NPD5223 Approved
0.6977 Remote Similarity NPD6336 Discontinued
0.6975 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6964 Remote Similarity NPD6399 Phase 3
0.696 Remote Similarity NPD6335 Approved
0.6947 Remote Similarity NPD7319 Approved
0.6942 Remote Similarity NPD4634 Approved
0.6937 Remote Similarity NPD46 Approved
0.6937 Remote Similarity NPD5785 Approved
0.6937 Remote Similarity NPD6698 Approved
0.6929 Remote Similarity NPD6016 Approved
0.6929 Remote Similarity NPD6015 Approved
0.6923 Remote Similarity NPD8293 Discontinued
0.6903 Remote Similarity NPD5282 Discontinued
0.688 Remote Similarity NPD6317 Approved
0.6875 Remote Similarity NPD5988 Approved
0.6875 Remote Similarity NPD5693 Phase 1
0.687 Remote Similarity NPD7902 Approved
0.6847 Remote Similarity NPD4753 Phase 2
0.6842 Remote Similarity NPD4629 Approved
0.6842 Remote Similarity NPD5210 Approved
0.6825 Remote Similarity NPD7327 Approved
0.6825 Remote Similarity NPD6314 Approved
0.6825 Remote Similarity NPD6313 Approved
0.6825 Remote Similarity NPD7328 Approved
0.6822 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6797 Remote Similarity NPD6909 Approved
0.6797 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6797 Remote Similarity NPD6908 Approved
0.6789 Remote Similarity NPD1694 Approved
0.6783 Remote Similarity NPD4697 Phase 3
0.6783 Remote Similarity NPD5221 Approved
0.6783 Remote Similarity NPD5222 Approved
0.6783 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6777 Remote Similarity NPD4730 Approved
0.6777 Remote Similarity NPD5128 Approved
0.6777 Remote Similarity NPD4729 Approved
0.6772 Remote Similarity NPD7516 Approved
0.6757 Remote Similarity NPD6672 Approved
0.6757 Remote Similarity NPD5737 Approved
0.6754 Remote Similarity NPD7748 Approved
0.675 Remote Similarity NPD4767 Approved
0.675 Remote Similarity NPD4768 Approved
0.6726 Remote Similarity NPD7515 Phase 2
0.6726 Remote Similarity NPD6079 Approved
0.6724 Remote Similarity NPD5173 Approved
0.6723 Remote Similarity NPD4754 Approved
0.6696 Remote Similarity NPD6673 Approved
0.6696 Remote Similarity NPD5328 Approved
0.6696 Remote Similarity NPD6080 Approved
0.6696 Remote Similarity NPD6904 Approved
0.6692 Remote Similarity NPD8328 Phase 3
0.6667 Remote Similarity NPD5248 Approved
0.6667 Remote Similarity NPD5251 Approved
0.6667 Remote Similarity NPD5778 Approved
0.6667 Remote Similarity NPD8033 Approved
0.6667 Remote Similarity NPD4202 Approved
0.6667 Remote Similarity NPD5250 Approved
0.6667 Remote Similarity NPD5249 Phase 3
0.6667 Remote Similarity NPD5779 Approved
0.6667 Remote Similarity NPD6868 Approved
0.6667 Remote Similarity NPD5247 Approved
0.6613 Remote Similarity NPD5217 Approved
0.6613 Remote Similarity NPD5216 Approved
0.6613 Remote Similarity NPD5215 Approved
0.6609 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6609 Remote Similarity NPD6001 Approved
0.6609 Remote Similarity NPD7900 Approved
0.6593 Remote Similarity NPD7260 Phase 2
0.6589 Remote Similarity NPD8377 Approved
0.6589 Remote Similarity NPD8294 Approved
0.6579 Remote Similarity NPD5281 Approved
0.6579 Remote Similarity NPD6050 Approved
0.6579 Remote Similarity NPD5284 Approved
0.6577 Remote Similarity NPD3618 Phase 1
0.6557 Remote Similarity NPD6412 Phase 2
0.6538 Remote Similarity NPD8296 Approved
0.6538 Remote Similarity NPD7503 Approved
0.6538 Remote Similarity NPD6921 Approved
0.6538 Remote Similarity NPD8378 Approved
0.6538 Remote Similarity NPD8379 Approved
0.6538 Remote Similarity NPD8380 Approved
0.6538 Remote Similarity NPD8335 Approved
0.6532 Remote Similarity NPD5169 Approved
0.6532 Remote Similarity NPD5135 Approved
0.6532 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6518 Remote Similarity NPD3573 Approved
0.6508 Remote Similarity NPD8133 Approved
0.6493 Remote Similarity NPD6033 Approved
0.6491 Remote Similarity NPD7838 Discovery
0.6491 Remote Similarity NPD5692 Phase 3
0.6486 Remote Similarity NPD5363 Approved
0.6486 Remote Similarity NPD5329 Approved
0.648 Remote Similarity NPD8413 Clinical (unspecified phase)
0.648 Remote Similarity NPD5127 Approved
0.6455 Remote Similarity NPD5362 Discontinued
0.6455 Remote Similarity NPD7154 Phase 3
0.6435 Remote Similarity NPD8035 Phase 2
0.6435 Remote Similarity NPD5694 Approved
0.6435 Remote Similarity NPD8034 Phase 2
0.6435 Remote Similarity NPD7637 Suspended
0.6429 Remote Similarity NPD6098 Approved
0.6429 Remote Similarity NPD7334 Approved
0.6429 Remote Similarity NPD6409 Approved
0.6429 Remote Similarity NPD7521 Approved
0.6429 Remote Similarity NPD5690 Phase 2
0.6429 Remote Similarity NPD6684 Approved
0.6429 Remote Similarity NPD7146 Approved
0.6429 Remote Similarity NPD5330 Approved
0.6412 Remote Similarity NPD8517 Approved
0.6412 Remote Similarity NPD8513 Phase 3
0.6412 Remote Similarity NPD8515 Approved
0.6412 Remote Similarity NPD8516 Approved
0.6396 Remote Similarity NPD4786 Approved
0.6396 Remote Similarity NPD4197 Approved
0.6387 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6357 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6339 Remote Similarity NPD1733 Clinical (unspecified phase)
0.633 Remote Similarity NPD4695 Discontinued
0.6328 Remote Similarity NPD5167 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data